neoTCR product selection
tumour
TUMOUR
The biological and potential therapeutic relevance of the captured candidate TCRs against the tumour neoantigens was then corroborated using precision genome-engineering of healthy donor T cells with each of the patient-isolated neoTCR candidates. The 